CSPC Innovation Pharmaceutical
300765.SZPre-clinicalCSPC Innovation Pharmaceutical is a publicly-traded Chinese biotech company that serves as the innovation arm of CSPC Pharmaceutical Group, one of China's largest pharmaceutical companies. The company focuses on developing first-in-class and best-in-class therapeutics through internal R&D and strategic partnerships. With a robust pipeline spanning oncology, immunology, and metabolic diseases, CSPC Innovation aims to address unmet medical needs in both domestic Chinese and international markets.
300765.SZ · Stock Price
Historical price data
AI Company Overview
CSPC Innovation Pharmaceutical is a publicly-traded Chinese biotech company that serves as the innovation arm of CSPC Pharmaceutical Group, one of China's largest pharmaceutical companies. The company focuses on developing first-in-class and best-in-class therapeutics through internal R&D and strategic partnerships. With a robust pipeline spanning oncology, immunology, and metabolic diseases, CSPC Innovation aims to address unmet medical needs in both domestic Chinese and international markets.
Technology Platform
Integrated drug discovery and development platform focusing on small molecules and biologics for diseases with high unmet medical need, particularly in therapeutic areas relevant to Chinese patient populations.
Opportunities
Risk Factors
Competitive Landscape
The company competes with established international pharmaceutical giants like Roche and Pfizer, as well as emerging Chinese biotech companies such as BeiGene and Innovent Biologics. Its competitive advantage lies in strong financial backing and deep understanding of the Chinese market.
Company Info
Trading
Contact
Therapeutic Areas
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile